Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of remimazolam tosilate on early cognitive function after sedation for gastrointestinal endoscopy in elderly patients
ChiCTR2100042084Phase 4Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in post-operative cognitive decline (POCD) (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: early cognitive function. Started Jan 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2100042084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042084.